PALMER ASHLEIGH (President and CEO) sold 0.9% of their position (24.16K shares) of PROVENTION BIO, INC. on the open market
Open‑market sale worth $248.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/20/2023ACC: 0001493152-23-002086
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-24.16K
Net shares
Net seller
$248.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
24.16K acquired · 48.33K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+24.16K
Price / share
$2.50
Trade value
$60.41K
% of position
0.9%
1/18/2023
2.57M→2.59M
Common Stock
Direct
Shares
−24.16K
Price / share
$10.27
Trade value
$248.06K
% of position
0.9%
1/18/2023
2.59M→2.57M
Total
Net shares
+0.00
Net value
-$187.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/18/2023 | M · Option Exercise | +24.16K | $2.50 | $60.41K | 0.9% | 2.57M | 2.59M |
| Common Stock Direct | 1/18/2023 | S · Sale | −24.16K | $10.27 | $248.06K | 0.9% | 2.59M | 2.57M |
| Total | +0.00 | -$187.65K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
24.16K shares
Shares
−24.16K
Strike price
2.5
Held after
517.55K
Exercisable
—
1/18/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock24.16K shares | 1/18/2023 | M · Option Exercise | −24.16K | 2.5 | — | 517.55K |